Daily ShareChat: Nuplex Industries
By Jenny Ruth
Resins company Nuplex's first-half earnings before interest, tax, depreciation and amortisation (EBITDA) of $68.8 million was ahead of his $64 million forecast, says Forsyth Barr analyst John Cairns.
The 10 cents a share first-half dividend was also ahead of the 7 cents he expected.
He has raised his forecast for full-year EBITDA by 4.1% to $131.4 million and raised his valuation from $3.26 a share to $3.61.
The company is expecting raw material costs to rise significantly and while it may recover some costs, a contraction in operating margin appears inevitable, Cairns says.
He says during the first half, resins demand varied with Asia the stand-out performer and European operations were boosted by increased exports to China. However, local European demand remained subdued and North American demand remained soft. Nuplex is focused on moving out of commodity resins into specialty resins, Cairns says.
Australian demand was resilient and there were signs of recovery in New Zealand towards the end of the first half.
Nuplex has raised its profit guidance three times since early November. "Whilst the upgrades are encouraging, the frequency of the upgrades highlights the uncertainty over market conditions, in particular the sustainability of underlying global resin demand and the impact of higher raw material input prices," Cairns says.
BROKER CALL: Forsyth Barr rate Nuplex as hold.
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Comments from our readers
No comments yet Add your comment:
Related News
Nuplex enters Russian joint venture Nuplex shares plunge 7.8% after profit warning Nuplex gains regulatory approval for Viverso purchase Nuplex may replace some bank debt with first issue of bonds in US private placement market Nuplex to buy Bayer MaterialScience's Viverso, forecasts 10% earnings growth Nuplex bows to shareholder pressure, withdraws director fee hike proposal Nuplex directors ask for shareholders for 33% pay rise Nuplex pays A$23.5 mln for Acquo Masterbatch Nuplex full year profit up 7.5 pct Daily ShareChat: Nuplex
NZX Annoucements for NPX
|